What They’re Watching: Tresa Thomas Massiongale

Tresa Thomas Massiongale, Chief Investment & Partnership Officer at Bloodworks NW, joins us in this edition of “What They’re Watching” to talk about the blood supply shortage.

What worries me, there are several things. Blood supply, not widely known how precarious the blood supply actually is. At any given time, about 40 percent of the U.S. population is technically eligible to give blood. About 4 percent of people do. We’re seeing multiple downward pressures in the blood industry. In a great way, blood is no longer as needed as much because of health care innovations. Surgeries are better, more precise, micro surgeries, all of that is fascinating and we’ve participated in that. Consolidation in the healthcare purchasing marketplace gives us less flexibility in terms of our contracts for blood and all those things really come together, as they do for many providers and in a variety of areas in healthcare, to give us less flexibility in the marketplace.

I love the work that integrates the target population into not just delivering the interventions but helping to frame the problem upstream. And collaboratively at the table as a peer, we know that that work literature on that approach, we know that that it’s always leading to greater outcomes that are address cost and care and certainly patient satisfaction.